Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

(NASDAQ:RARE), NOVATO, Calif., May 20, 2025 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of 44,805 restricted stock units of the company's common stock to 20 newly hired non-executive officers of the company. The […]

First Busey Corporation Closes Depositary Share Offering

First Busey Corporation Closes Depositary Share Offering GlobeNewswire May 20, 2025 LEAWOOD, Kan., May 20, 2025 (GLOBE NEWSWIRE) — First Busey Corporation (“Busey”) (Nasdaq: BUSE), the holding company for Busey Bank and CrossFirst Bank, today announced the closing of its previously announced underwritten public offering of 8,600,000 depositary shares (inclusive of 600,000 depositary shares offered

Latin Metals Announces Closing of Oversubscribed Private Placement for Gross Proceeds of $1.33 Million

Latin Metals Announces Closing of Oversubscribed Private Placement for Gross Proceeds of $1.33 Million GlobeNewswire May 20, 2025 VANCOUVER, British Columbia, May 20, 2025 (GLOBE NEWSWIRE) — Latin Metals Inc. (“Latin Metals” or the “Company”) – (TSXV: LMS) (OTCQB: LMSQF) is pleased to announce the closing of its previously announced non-brokered private placement (the “Financing”)

Helium Evolution Announces Filing of First Quarter 2025 Financial Results

Helium Evolution Announces Filing of First Quarter 2025 Financial Results GlobeNewswire May 20, 2025 CALGARY, Alberta, May 20, 2025 (GLOBE NEWSWIRE) — Helium Evolution Incorporated (TSXV:HEVI) (“HEVI” or the “Company“), a Canadian-based helium exploration company focused on developing assets in southern Saskatchewan, today announced the filing of the Company's interim condensed financial statements and associated

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4)

Ultragenyx Reports Inducement Grant Under Nasdaq Listing Rule 5635(c)(4) GlobeNewswire May 20, 2025 NOVATO, Calif., May 20, 2025 (GLOBE NEWSWIRE) — Ultragenyx Pharmaceutical Inc. (NASDAQ: RARE), a biopharmaceutical company focused on the development and commercialization of novel therapies for rare and ultra-rare diseases, today reported the grant of 44,805 restricted stock units of the company's

Segra International Acquires Klonetics to Expand Nursery Capacity and Accelerate Growth

Segra International Acquires Klonetics to Expand Nursery Capacity and Accelerate Growth GlobeNewswire May 20, 2025 VANCOUVER, British Columbia, May 20, 2025 (GLOBE NEWSWIRE) — Segra International (“Segra”), a global leader in cannabis agriculture technology, proudly announces its strategic amalgamation with Klonetics Plant Science Inc., a licensed cannabis nursery and cultivation company based in Kelowna, BC.

ROSEN, NATIONAL INVESTOR RIGHTS COUNSEL, Encourages NAPCO Security Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NSSC

(NASDAQ:NSSC), NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of NAPCO Security Technologies, Inc. (NASDAQ: NSSC) between February 5, 2024 and February 3, 2025, both dates inclusive (the “Class Period”), of the important June 24, 2025 lead plaintiff deadline. SO WHAT:

ROSEN, NATIONAL INVESTOR RIGHTS COUNSEL, Encourages NAPCO Security Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NSSC

ROSEN, NATIONAL INVESTOR RIGHTS COUNSEL, Encourages NAPCO Security Technologies, Inc. Investors to Secure Counsel Before Important Deadline in Securities Class Action – NSSC GlobeNewswire May 20, 2025 NEW YORK, May 20, 2025 (GLOBE NEWSWIRE) — WHY: Rosen Law Firm, a global investor rights law firm, reminds purchasers of securities of NAPCO Security Technologies, Inc. (NASDAQ:

Day of Action on May 22 Highlights Need for Visibility of ALS

May is Awareness Month for Amyotrophic Lateral Sclerosis (ALS), also known as Lou Gehrig's disease In honor of ALS Awareness Month, I AM ALS is rallying the nation on Thursday, May 22 for a Day of Action to shine a light on the devastating realities of Amyotrophic Lateral Sclerosis (ALS), amplify the voices of those

Global Alzheimer’s Platform Foundation Applauds FDA Authorization of the First Blood-Based Diagnostic Test for Assessing Alzheimer’s Disease

WASHINGTON, May 20, 2025 (GLOBE NEWSWIRE) — The Global Alzheimer's Platform Foundation(R) (GAP) applauds the FDA's clearance of the first blood test to diagnose Alzheimer's disease. Fujirebio's Lumipulse G pTau217/ss-Amyloid 1-42 Plasma Ratio invitro diagnostic (IVD) represents the first blood-based test available to physicians and their patients for early detection of amyloid plaques associated with

Scroll to Top